| Literature DB >> 15331755 |
R A Du Pasquier1, J E Schmitz, J Jean-Jacques, Y Zheng, J Gordon, K Khalili, N L Letvin, I J Koralnik.
Abstract
The polyomavirus JC (JCV) infects 85% of healthy individuals, and its reactivation in a limited number of immunosuppressed people causes progressive multifocal leukoencephalopathy (PML), a severe demyelinating disease of the central nervous system. We hypothesized that JCV-specific cytotoxic T lymphocytes (CTLs) might control JCV replication in healthy individuals, blocking the evolution of PML. Using 51Cr release and tetramer staining assays, we show that 8 of 11 HLA-A*0201+ healthy subjects (73%) harbor detectable JCV-specific CD8+ CTLs that recognize one or two epitopes of JCV VP1 protein, the HLA-A*0201-restricted VP1p36 and VPp1100 epitopes. We determined that the frequency of JCV VP1 epitope-specific CTLs varied from less than 1/100,000 to 1/2,494 peripheral blood mononuclear cells. More individuals had JCV VP1-specific than cytomegalovirus-specific CTLs (8 of 11 subjects [73%] versus 2 of 10 subjects [20%], respectively). These results show that a CD8+-T-cell response against JCV is commonly found in immunocompetent people and suggest that these cells might protect against the development of PML. Copyright 2004 American Society for MicrobiologyEntities:
Mesh:
Substances:
Year: 2004 PMID: 15331755 PMCID: PMC514969 DOI: 10.1128/JVI.78.18.10206-10210.2004
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103